Aligos Therapeutics, Inc. (ALGS)
NASDAQ·Healthcare·Biotechnology
$6.31
-1.87%
Mkt Cap $43.23M
Analyst Ratings
No recent rating data.
Price Target (3 analysts)
$20.00
Range $20.00 – $20.00
Implied Upside
+217.0%
Consensus $20.00 vs current $6.31
NASDAQ·Healthcare·Biotechnology
$6.31
-1.87%
Mkt Cap $43.23M
No recent rating data.
Price Target (3 analysts)
$20.00
Range $20.00 – $20.00
+217.0%
Consensus $20.00 vs current $6.31